Myant

Myant Health develops continuous cardiovascular screening solutions through its SKIIN™ platform, a Health Canada-licensed Class II medical device. Established in 2022 and based in Mississauga, Ontario, the company manufactures wearable cardiac monitoring technology using textile computing to enable 14-day continuous ECG monitoring without traditional adhesive electrodes.

The company's approach centers on replacing episodic cardiac testing with continuous data streams through comfortable, washable smart garments. The Heart-Aid Kit™ delivers remote patient monitoring capabilities that connect patients, caregivers, and clinicians through a PIPEDA and HIPAA-compliant platform. The technology has been validated through over 15,000 peer-reviewed accuracy studies.

Myant Health serves cardiology practices, health systems, and diagnostic laboratories across Ontario, with partnerships including PACE Cardiology, WELL Health, and Dynacare. The company's platform supports OHIP billing codes G694, G695, and G696 for extended cardiac monitoring in Ontario.

Consider Myant Health when seeking to improve diagnostic yield for paroxysmal arrhythmias through extended monitoring periods with better patient compliance. Their textile-based approach addresses common patient complaints about adhesive irritation and device discomfort that limit traditional Holter study completion rates.

The managed service model handles logistics, patient education, and clinical reporting, allowing practices to offer extended monitoring without significant operational overhead. Best suited for Ontario-based cardiology practices already billing through OHIP or health systems looking to pilot innovative remote monitoring technologies.

Myant Health exclusively serves the healthcare sector with focus on cardiology and cardiovascular screening. The company holds Health Canada Class II medical device certification and maintains HIPAA and PIPEDA compliance for handling protected health information. Their technology specifically addresses cardiac arrhythmia detection including atrial fibrillation screening.

The platform integrates with Ontario's OHIP billing system and partners with established cardiology practices, diagnostic laboratories, and health systems. Clinical validation includes presentations at the Canadian Cardiovascular Congress and Heart Rhythm Society conferences.

Cardiology practices and health systems in Ontario seeking to expand diagnostic capabilities for intermittent arrhythmia detection. Organizations that want to improve patient experience in extended cardiac monitoring while maintaining clinical accuracy and regulatory compliance. Best suited for providers comfortable with technology adoption and interested in value-based care approaches to cardiac screening.